For Release: May 6, 2014
Screening 40- to 49-year-old women for breast cancer has additional benefits beyond the proven decrease in mortality rate. Patients screened with mammography are statistically less likely to undergo chemotherapy, avoiding the associated toxic morbidities. Screening mammography also helps identify a subset of patients at increased risk of breast cancer by diagnosing high-risk lesions.
The majority of high-risk lesions identified in a retrospective chart review were found in screened patients. Identifying patients at high risk may allow for the administration of chemoprevention, decreasing the risk of subsequent breast cancer development. The identification of high-risk lesions may also lead to supplemental screening MRI, which has the added benefit of detecting future mammographically occult malignancies in high-risk patients.
"When the U.S. Preventive Services Task Force guidelines were published in 2009, confusion was created among patients and primary care providers on when and if 40- to 49-year-old women should be screened," said Nelly Salem of University Hospitals–Case Western Reserve. "Without screening mammography, these asymptomatic high-risk women would be unaware of their risk and the opportunity to decrease their risk of subsequent breast cancer development with use of chemoprevention."
Dr. Salem will present her study on May 6 at the 2014 ARRS Annual Meeting in San Diego, CA.
Founded in 1900, ARRS is the first and oldest radiology society in the United States. The society was originally named the American Roentgen Society after its founder, Wilhelm Roentgen, who discovered the x-ray. ARRS has been an international forum for progress in radiology and is dedicated to the goal of the advancement of medicine through the science of radiology and its allied sciences. The goal of the ARRS is maintained through an annual scientific and educational meeting and publication of the American Journal of Roentgenology or AJR. ARRS is located in Leesburg, VA.